[시장보고서]융합 생검 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 생검 경로별(경직장적, 경회음적), 최종사용자별(병원, 진단 센터, 외래 진료 센터), 지역별, 경쟁별(2020-2030년)

융합 생검 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 생검 경로별(경직장적, 경회음적), 최종사용자별(병원, 진단 센터, 외래 진료 센터), 지역별, 경쟁별(2020-2030년)

Fusion Biopsy Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Biopsy Route (Transrectal, Transperineal), By End-User (Hospitals, Diagnostic Centers, Ambulatory Care Centers), By Region, Competition, 2020-2030F

상품코드 : 1881800

리서치사 : TechSci Research

발행일 : 2025년 11월

페이지 정보 : 영문 180 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,708,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 8,199,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 11,926,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 융합 생검 시장은 2024년에 6억 1,892만 달러로 평가되었으며, 2030년까지 CAGR 8.6%로 성장하여 10억 1,534만 달러에 달할 것으로 예측됩니다.

융합 생검은 자기공명영상법(MRI)과 실시간 초음파를 통합한 첨단 진단기술로, 주로 전립선 내 의심스러운 병변을 정확하게 표적화하여 조직 샘플을 채취합니다. 이 방법은 생검침을 특정 이상 부위에 유도하여 진단 정확도를 높여 기존의 무작위 샘플링에 비해 크게 개선된 진단 정확도를 제공합니다. 융합 생검 시장의 성장은 전 세계 전립선암 유병률 증가와 검출 정확도 및 시술 정확도를 향상시키는 영상 기술의 지속적인 발전으로 인해 크게 견인되고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	6억 1,892만 달러
시장 규모 : 2030년	10억 1,534만 달러
CAGR : 2025-2030년	8.6%
가장 빠르게 성장하는 부문	경직장
최대 시장	북미

주요 시장 촉진요인

전립선암의 전 세계 유병률 증가가 주요 시장 촉진요인으로 작용하여 정밀 진단 도구에 대한 수요가 증가하고 있습니다. 신규 진단 건수가 꾸준히 증가하고 있는 가운데, 환자의 치료 결과를 개선하기 위해서는 고도의 검출 방법이 필수적입니다.

주요 시장 과제

융합 생검 시스템 및 시술과 관련된 높은 비용과 종합적인 보험 적용의 어려움으로 인해 시장 확대에 큰 걸림돌이 되고 있습니다. 이러한 첨단 진단 플랫폼에 필요한 막대한 자본 투자는 의료 서비스 제공자에게 큰 재정적 부담으로 작용하고 있습니다.

주요 시장 동향

인공지능(AI)과 머신러닝의 통합은 진단 정확도와 시술 효율을 향상시켜 전 세계 융합생검 시장을 변화시키는 중요한 트렌드입니다. AI 알고리즘은 MRI와 같은 복잡한 영상 데이터를 분석하여 의심스러운 병변을 보다 정확하게 찾아내어, 의료진 간 편차를 줄이고 의료비 절감으로 이어질 수 있습니다.

영문목차

The Global Fusion Biopsy Market, valued at USD 618.92 Million in 2024, is projected to experience a CAGR of 8.6% to reach USD 1015.34 Million by 2030. Fusion biopsy is an advanced diagnostic technique that integrates magnetic resonance imaging with real-time ultrasound to precisely target suspicious lesions for tissue sampling, predominantly within the prostate. This method enhances diagnostic accuracy by guiding the biopsy needle to specific abnormal areas, a considerable improvement over traditional random sampling. The market for fusion biopsy is significantly driven by the increasing global prevalence of prostate cancer and continuous advancements in imaging technologies that improve detection and procedural precision.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 618.92 Million
Market Size 2030	USD 1015.34 Million
CAGR 2025-2030	8.6%
Fastest Growing Segment	Transrectal
Largest Market	North America

Key Market Drivers

The increasing global prevalence of prostate cancer is a primary market driver, fueling demand for precise diagnostic tools. With new diagnoses consistently rising, advanced detection methods are critical for improved patient outcomes. According to the International Agency for Research on Cancer's Global Cancer Observatory, in 2022, approximately 1.5 million new cases of prostate cancer were reported globally, underscoring this persistent demand. Simultaneously, continuous advancements in medical imaging technologies significantly impact market expansion. Improvements in MRI and ultrasound systems, with sophisticated software, enhance fusion biopsy precision. These technological evolutions enable more accurate lesion identification.

Key Market Challenges

The elevated cost associated with fusion biopsy systems and procedures, alongside challenges in securing comprehensive reimbursement, significantly impedes market expansion. The high capital investment required for these advanced diagnostic platforms creates a substantial financial burden for healthcare providers. This limitation particularly affects institutions with restricted budgets and healthcare systems in developing economies, curtailing their ability to acquire and implement fusion biopsy technology.

Key Market Trends

The integration of Artificial Intelligence and Machine Learning is a significant trend transforming the global fusion biopsy market by enhancing diagnostic accuracy and procedural efficiency. AI algorithms analyze complex imaging data, such as MRI, to identify suspicious lesions with greater precision, reducing inter-operator variability and potentially lowering healthcare costs. This technological advancement also facilitates more efficient workflows, with AI systems capable of optimizing lesion segmentation and image texture analysis.

Key Market Players

Eigen Health Ltd
Koninklijke Philips N.V.
Hitachi, Ltd.
MedCom Inc
Esaoate SpA
KOELIS SAS
Focal Healthcare Inc
UC-Care Medical Systems Ltd.
GeoScan Medical

Report Scope:

In this report, the Global Fusion Biopsy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fusion Biopsy Market, By Biopsy Route:

Transrectal
Transperineal

Fusion Biopsy Market, By End-User:

Hospitals
Diagnostic Centers
Ambulatory Care Centers

Fusion Biopsy Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Fusion Biopsy Market.

Available Customizations:

Global Fusion Biopsy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Fusion Biopsy Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Biopsy Route (Transrectal, Transperineal)
- 5.2.2. By End-User (Hospitals, Diagnostic Centers, Ambulatory Care Centers)
- 5.2.3. By Region
- 5.2.4. By Company (2024)
5.3. Market Map

6. North America Fusion Biopsy Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Biopsy Route
- 6.2.2. By End-User
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Fusion Biopsy Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Biopsy Route
    - 6.3.1.2.2. By End-User
- 6.3.2. Canada Fusion Biopsy Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Biopsy Route
    - 6.3.2.2.2. By End-User
- 6.3.3. Mexico Fusion Biopsy Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Biopsy Route
    - 6.3.3.2.2. By End-User

7. Europe Fusion Biopsy Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Biopsy Route
- 7.2.2. By End-User
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Fusion Biopsy Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Biopsy Route
    - 7.3.1.2.2. By End-User
- 7.3.2. France Fusion Biopsy Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Biopsy Route
    - 7.3.2.2.2. By End-User
- 7.3.3. United Kingdom Fusion Biopsy Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Biopsy Route
    - 7.3.3.2.2. By End-User
- 7.3.4. Italy Fusion Biopsy Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Biopsy Route
    - 7.3.4.2.2. By End-User
- 7.3.5. Spain Fusion Biopsy Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Biopsy Route
    - 7.3.5.2.2. By End-User

8. Asia Pacific Fusion Biopsy Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Biopsy Route
- 8.2.2. By End-User
- 8.2.3. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Fusion Biopsy Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Biopsy Route
    - 8.3.1.2.2. By End-User
- 8.3.2. India Fusion Biopsy Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Biopsy Route
    - 8.3.2.2.2. By End-User
- 8.3.3. Japan Fusion Biopsy Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Biopsy Route
    - 8.3.3.2.2. By End-User
- 8.3.4. South Korea Fusion Biopsy Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Biopsy Route
    - 8.3.4.2.2. By End-User
- 8.3.5. Australia Fusion Biopsy Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Biopsy Route
    - 8.3.5.2.2. By End-User

9. Middle East & Africa Fusion Biopsy Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Biopsy Route
- 9.2.2. By End-User
- 9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Fusion Biopsy Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Biopsy Route
    - 9.3.1.2.2. By End-User
- 9.3.2. UAE Fusion Biopsy Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Biopsy Route
    - 9.3.2.2.2. By End-User
- 9.3.3. South Africa Fusion Biopsy Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Biopsy Route
    - 9.3.3.2.2. By End-User

10. South America Fusion Biopsy Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Biopsy Route
- 10.2.2. By End-User
- 10.2.3. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Fusion Biopsy Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Biopsy Route
    - 10.3.1.2.2. By End-User
- 10.3.2. Colombia Fusion Biopsy Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Biopsy Route
    - 10.3.2.2.2. By End-User
- 10.3.3. Argentina Fusion Biopsy Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Biopsy Route
    - 10.3.3.2.2. By End-User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Fusion Biopsy Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Eigen Health Ltd
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Koninklijke Philips N.V.
15.3. Hitachi, Ltd.
15.4. MedCom Inc
15.5. Esaoate SpA
15.6. KOELIS SAS
15.7. Focal Healthcare Inc
15.8. UC-Care Medical Systems Ltd.
15.9. GeoScan Medical

한글목차

주요 시장 촉진요인

주요 시장 과제

주요 시장 동향

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 융합 생검 시장 전망

제6장 북미의 융합 생검 시장 전망

제7장 유럽의 융합 생검 시장 전망

제8장 아시아태평양의 융합 생검 시장 전망

제9장 중동 및 아프리카의 융합 생검 시장 전망

제10장 남미의 융합 생검 시장 전망

제11장 시장 역학

제12장 시장 동향과 발전

제13장 세계의 융합 생검 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

제15장 경쟁 구도

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항